Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shingrix in SLE Patients
NCT06001606Phase 3Unknown
- Sponsor
- Seoul National University Hospital
- Start
- May 2023
- Primary completion
- Apr 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Zoster vaccine recombinant in herpes zoster (HZ), sponsored by Seoul National University Hospital. Status: unknown.
02
Drugs
Zoster vaccine recombinant
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT06001606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06001606.